TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunotherapy
Data on immunotherapy discussed by J. Shojaeian and colleagues
June 30th, 2009
"To develop an efficient dendritic cell (DC)-based immunotherapy protocol, we examined whether simultaneous pulsing of DCs with a given antigen and a third-party antigen could enhance their antigen presentation capacity. Purified splenic DCs of Balb/c mice were pulsed separately with immunoglobulin G, ovalbumin, conalbumin, P15 peptide of Mycobacterium tuberculosis, and prostate-specific antigen or double combinations of the aforementioned antigens," scientists writing in the Journal of Immunotherapy report. "In some settings, DCs pulsed with I antigen were mixed equally with those pulsed with another antigen. Antigen-pulsed DCs were injected into the footpad of...
Source: TB & Outbreaks Week (2009-06-30)
|
